Spotlight exclusive

Target discovery and validation in systemic sclerosis

In this poster, learn more about the recent research at Charles River Laboratories to validate novel drug targets for systemic sclerosis.

Go to the profile of RxNet
Feb 27, 2018
Target discovery program in systemic sclerosis: Charles River Laboratories

View the full size PDF here

Do you want to learn more about drug target validation? Check out our exclusive content:
Go to the profile of RxNet


A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.